0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Perindopril tert-Butylamine Tablets Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-34G18397
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Perindopril tert Butylamine Tablets Market Research Report 2024
BUY CHAPTERS

Global Perindopril tert-Butylamine Tablets Market Research Report 2024

Code: QYRE-Auto-34G18397
Report
December 2024
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Perindopril tert-Butylamine Tablets Market Size

The global market for Perindopril tert-Butylamine Tablets was valued at US$ 257 million in the year 2023 and is projected to reach a revised size of US$ 358 million by 2030, growing at a CAGR of 4.8% during the forecast period.

Perindopril tert-Butylamine Tablets Market

Perindopril tert-Butylamine Tablets Market

Perindopril is a medicine used to treat high blood pressure (hypertension) and heart failure. It's also prescribed after a heart attack. Perindopril helps to reduce the risk of future strokes and heart attacks.
North American market for Perindopril tert-Butylamine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Perindopril tert-Butylamine Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Perindopril tert-Butylamine Tablets include Servier, Haisco Pharmaceutical, Ningbo Menovo TianKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Shanghai Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Perindopril tert-Butylamine Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perindopril tert-Butylamine Tablets.
The Perindopril tert-Butylamine Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Perindopril tert-Butylamine Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Perindopril tert-Butylamine Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Perindopril tert-Butylamine Tablets Market Report

Report Metric Details
Report Name Perindopril tert-Butylamine Tablets Market
Accounted market size in year US$ 257 million
Forecasted market size in 2030 US$ 358 million
CAGR 4.8%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
  • 4mg
  • 8mg
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Servier, Haisco Pharmaceutical, Ningbo Menovo TianKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Shanghai Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Perindopril tert-Butylamine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Perindopril tert-Butylamine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Perindopril tert-Butylamine Tablets Market growing?

Ans: The Perindopril tert-Butylamine Tablets Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Perindopril tert-Butylamine Tablets Market size in 2030?

Ans: The Perindopril tert-Butylamine Tablets Market size in 2030 will be US$ 358 million.

Who are the main players in the Perindopril tert-Butylamine Tablets Market report?

Ans: The main players in the Perindopril tert-Butylamine Tablets Market are Servier, Haisco Pharmaceutical, Ningbo Menovo TianKang Pharmaceutical, Zhejiang Huahai Pharmaceutical, Shanghai Pharmaceuticals

What are the Application segmentation covered in the Perindopril tert-Butylamine Tablets Market report?

Ans: The Applications covered in the Perindopril tert-Butylamine Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Perindopril tert-Butylamine Tablets Market report?

Ans: The Types covered in the Perindopril tert-Butylamine Tablets Market report are 4mg, 8mg, Others

Recommended Reports

Hypertension & Heart

Tablet & API Markets

Treatment & Therapeutics

1 Perindopril tert-Butylamine Tablets Market Overview
1.1 Product Definition
1.2 Perindopril tert-Butylamine Tablets by Type
1.2.1 Global Perindopril tert-Butylamine Tablets Market Value Comparison by Type (2024-2030)
1.2.2 4mg
1.2.3 8mg
1.2.4 Others
1.3 Perindopril tert-Butylamine Tablets by Application
1.3.1 Global Perindopril tert-Butylamine Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Perindopril tert-Butylamine Tablets Market Size Estimates and Forecasts
1.4.1 Global Perindopril tert-Butylamine Tablets Revenue 2019-2030
1.4.2 Global Perindopril tert-Butylamine Tablets Sales 2019-2030
1.4.3 Global Perindopril tert-Butylamine Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Perindopril tert-Butylamine Tablets Market Competition by Manufacturers
2.1 Global Perindopril tert-Butylamine Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Perindopril tert-Butylamine Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Perindopril tert-Butylamine Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Perindopril tert-Butylamine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Perindopril tert-Butylamine Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Perindopril tert-Butylamine Tablets, Product Type & Application
2.7 Global Key Manufacturers of Perindopril tert-Butylamine Tablets, Date of Enter into This Industry
2.8 Global Perindopril tert-Butylamine Tablets Market Competitive Situation and Trends
2.8.1 Global Perindopril tert-Butylamine Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Perindopril tert-Butylamine Tablets Players Market Share by Revenue
2.8.3 Global Perindopril tert-Butylamine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Perindopril tert-Butylamine Tablets Market Scenario by Region
3.1 Global Perindopril tert-Butylamine Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Perindopril tert-Butylamine Tablets Sales by Region: 2019-2030
3.2.1 Global Perindopril tert-Butylamine Tablets Sales by Region: 2019-2024
3.2.2 Global Perindopril tert-Butylamine Tablets Sales by Region: 2025-2030
3.3 Global Perindopril tert-Butylamine Tablets Revenue by Region: 2019-2030
3.3.1 Global Perindopril tert-Butylamine Tablets Revenue by Region: 2019-2024
3.3.2 Global Perindopril tert-Butylamine Tablets Revenue by Region: 2025-2030
3.4 North America Perindopril tert-Butylamine Tablets Market Facts & Figures by Country
3.4.1 North America Perindopril tert-Butylamine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Perindopril tert-Butylamine Tablets Sales by Country (2019-2030)
3.4.3 North America Perindopril tert-Butylamine Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Perindopril tert-Butylamine Tablets Market Facts & Figures by Country
3.5.1 Europe Perindopril tert-Butylamine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Perindopril tert-Butylamine Tablets Sales by Country (2019-2030)
3.5.3 Europe Perindopril tert-Butylamine Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Perindopril tert-Butylamine Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Perindopril tert-Butylamine Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Perindopril tert-Butylamine Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Perindopril tert-Butylamine Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Perindopril tert-Butylamine Tablets Market Facts & Figures by Country
3.7.1 Latin America Perindopril tert-Butylamine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Perindopril tert-Butylamine Tablets Sales by Country (2019-2030)
3.7.3 Latin America Perindopril tert-Butylamine Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Perindopril tert-Butylamine Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Perindopril tert-Butylamine Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Perindopril tert-Butylamine Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Perindopril tert-Butylamine Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Perindopril tert-Butylamine Tablets Sales by Type (2019-2030)
4.1.1 Global Perindopril tert-Butylamine Tablets Sales by Type (2019-2024)
4.1.2 Global Perindopril tert-Butylamine Tablets Sales by Type (2025-2030)
4.1.3 Global Perindopril tert-Butylamine Tablets Sales Market Share by Type (2019-2030)
4.2 Global Perindopril tert-Butylamine Tablets Revenue by Type (2019-2030)
4.2.1 Global Perindopril tert-Butylamine Tablets Revenue by Type (2019-2024)
4.2.2 Global Perindopril tert-Butylamine Tablets Revenue by Type (2025-2030)
4.2.3 Global Perindopril tert-Butylamine Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Perindopril tert-Butylamine Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Perindopril tert-Butylamine Tablets Sales by Application (2019-2030)
5.1.1 Global Perindopril tert-Butylamine Tablets Sales by Application (2019-2024)
5.1.2 Global Perindopril tert-Butylamine Tablets Sales by Application (2025-2030)
5.1.3 Global Perindopril tert-Butylamine Tablets Sales Market Share by Application (2019-2030)
5.2 Global Perindopril tert-Butylamine Tablets Revenue by Application (2019-2030)
5.2.1 Global Perindopril tert-Butylamine Tablets Revenue by Application (2019-2024)
5.2.2 Global Perindopril tert-Butylamine Tablets Revenue by Application (2025-2030)
5.2.3 Global Perindopril tert-Butylamine Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Perindopril tert-Butylamine Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Servier
6.1.1 Servier Company Information
6.1.2 Servier Description and Business Overview
6.1.3 Servier Perindopril tert-Butylamine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Servier Perindopril tert-Butylamine Tablets Product Portfolio
6.1.5 Servier Recent Developments/Updates
6.2 Haisco Pharmaceutical
6.2.1 Haisco Pharmaceutical Company Information
6.2.2 Haisco Pharmaceutical Description and Business Overview
6.2.3 Haisco Pharmaceutical Perindopril tert-Butylamine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Haisco Pharmaceutical Perindopril tert-Butylamine Tablets Product Portfolio
6.2.5 Haisco Pharmaceutical Recent Developments/Updates
6.3 Ningbo Menovo TianKang Pharmaceutical
6.3.1 Ningbo Menovo TianKang Pharmaceutical Company Information
6.3.2 Ningbo Menovo TianKang Pharmaceutical Description and Business Overview
6.3.3 Ningbo Menovo TianKang Pharmaceutical Perindopril tert-Butylamine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ningbo Menovo TianKang Pharmaceutical Perindopril tert-Butylamine Tablets Product Portfolio
6.3.5 Ningbo Menovo TianKang Pharmaceutical Recent Developments/Updates
6.4 Zhejiang Huahai Pharmaceutical
6.4.1 Zhejiang Huahai Pharmaceutical Company Information
6.4.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.4.3 Zhejiang Huahai Pharmaceutical Perindopril tert-Butylamine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zhejiang Huahai Pharmaceutical Perindopril tert-Butylamine Tablets Product Portfolio
6.4.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.5 Shanghai Pharmaceuticals
6.5.1 Shanghai Pharmaceuticals Company Information
6.5.2 Shanghai Pharmaceuticals Description and Business Overview
6.5.3 Shanghai Pharmaceuticals Perindopril tert-Butylamine Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Pharmaceuticals Perindopril tert-Butylamine Tablets Product Portfolio
6.5.5 Shanghai Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Perindopril tert-Butylamine Tablets Industry Chain Analysis
7.2 Perindopril tert-Butylamine Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Perindopril tert-Butylamine Tablets Production Mode & Process
7.4 Perindopril tert-Butylamine Tablets Sales and Marketing
7.4.1 Perindopril tert-Butylamine Tablets Sales Channels
7.4.2 Perindopril tert-Butylamine Tablets Distributors
7.5 Perindopril tert-Butylamine Tablets Customers
8 Perindopril tert-Butylamine Tablets Market Dynamics
8.1 Perindopril tert-Butylamine Tablets Industry Trends
8.2 Perindopril tert-Butylamine Tablets Market Drivers
8.3 Perindopril tert-Butylamine Tablets Market Challenges
8.4 Perindopril tert-Butylamine Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Perindopril tert-Butylamine Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Perindopril tert-Butylamine Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Perindopril tert-Butylamine Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Perindopril tert-Butylamine Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Perindopril tert-Butylamine Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Perindopril tert-Butylamine Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Perindopril tert-Butylamine Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Perindopril tert-Butylamine Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Perindopril tert-Butylamine Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Perindopril tert-Butylamine Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Perindopril tert-Butylamine Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Perindopril tert-Butylamine Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Perindopril tert-Butylamine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perindopril tert-Butylamine Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Perindopril tert-Butylamine Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Perindopril tert-Butylamine Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Perindopril tert-Butylamine Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Perindopril tert-Butylamine Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Perindopril tert-Butylamine Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Perindopril tert-Butylamine Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Perindopril tert-Butylamine Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Perindopril tert-Butylamine Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Perindopril tert-Butylamine Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Perindopril tert-Butylamine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Perindopril tert-Butylamine Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Perindopril tert-Butylamine Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Perindopril tert-Butylamine Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Perindopril tert-Butylamine Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Perindopril tert-Butylamine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Perindopril tert-Butylamine Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Perindopril tert-Butylamine Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Perindopril tert-Butylamine Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Perindopril tert-Butylamine Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Perindopril tert-Butylamine Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Perindopril tert-Butylamine Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Perindopril tert-Butylamine Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Perindopril tert-Butylamine Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Perindopril tert-Butylamine Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Perindopril tert-Butylamine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Perindopril tert-Butylamine Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Perindopril tert-Butylamine Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Perindopril tert-Butylamine Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Perindopril tert-Butylamine Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Perindopril tert-Butylamine Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Perindopril tert-Butylamine Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Perindopril tert-Butylamine Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Perindopril tert-Butylamine Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Perindopril tert-Butylamine Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Perindopril tert-Butylamine Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Perindopril tert-Butylamine Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Perindopril tert-Butylamine Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Perindopril tert-Butylamine Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Perindopril tert-Butylamine Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Perindopril tert-Butylamine Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Perindopril tert-Butylamine Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Perindopril tert-Butylamine Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Perindopril tert-Butylamine Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Perindopril tert-Butylamine Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Perindopril tert-Butylamine Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Perindopril tert-Butylamine Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Perindopril tert-Butylamine Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Perindopril tert-Butylamine Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Perindopril tert-Butylamine Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Perindopril tert-Butylamine Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Perindopril tert-Butylamine Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Perindopril tert-Butylamine Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Perindopril tert-Butylamine Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Perindopril tert-Butylamine Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. Servier Company Information
 Table 71. Servier Description and Business Overview
 Table 72. Servier Perindopril tert-Butylamine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Servier Perindopril tert-Butylamine Tablets Product
 Table 74. Servier Recent Developments/Updates
 Table 75. Haisco Pharmaceutical Company Information
 Table 76. Haisco Pharmaceutical Description and Business Overview
 Table 77. Haisco Pharmaceutical Perindopril tert-Butylamine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Haisco Pharmaceutical Perindopril tert-Butylamine Tablets Product
 Table 79. Haisco Pharmaceutical Recent Developments/Updates
 Table 80. Ningbo Menovo TianKang Pharmaceutical Company Information
 Table 81. Ningbo Menovo TianKang Pharmaceutical Description and Business Overview
 Table 82. Ningbo Menovo TianKang Pharmaceutical Perindopril tert-Butylamine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Ningbo Menovo TianKang Pharmaceutical Perindopril tert-Butylamine Tablets Product
 Table 84. Ningbo Menovo TianKang Pharmaceutical Recent Developments/Updates
 Table 85. Zhejiang Huahai Pharmaceutical Company Information
 Table 86. Zhejiang Huahai Pharmaceutical Description and Business Overview
 Table 87. Zhejiang Huahai Pharmaceutical Perindopril tert-Butylamine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Zhejiang Huahai Pharmaceutical Perindopril tert-Butylamine Tablets Product
 Table 89. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
 Table 90. Shanghai Pharmaceuticals Company Information
 Table 91. Shanghai Pharmaceuticals Description and Business Overview
 Table 92. Shanghai Pharmaceuticals Perindopril tert-Butylamine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Shanghai Pharmaceuticals Perindopril tert-Butylamine Tablets Product
 Table 94. Shanghai Pharmaceuticals Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Perindopril tert-Butylamine Tablets Distributors List
 Table 98. Perindopril tert-Butylamine Tablets Customers List
 Table 99. Perindopril tert-Butylamine Tablets Market Trends
 Table 100. Perindopril tert-Butylamine Tablets Market Drivers
 Table 101. Perindopril tert-Butylamine Tablets Market Challenges
 Table 102. Perindopril tert-Butylamine Tablets Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Perindopril tert-Butylamine Tablets
 Figure 2. Global Perindopril tert-Butylamine Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Perindopril tert-Butylamine Tablets Market Share by Type: 2023 & 2030
 Figure 4. 4mg Product Picture
 Figure 5. 8mg Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Perindopril tert-Butylamine Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Perindopril tert-Butylamine Tablets Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Perindopril tert-Butylamine Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Perindopril tert-Butylamine Tablets Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Perindopril tert-Butylamine Tablets Sales (2019-2030) & (K Units)
 Figure 15. Global Perindopril tert-Butylamine Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 16. Perindopril tert-Butylamine Tablets Report Years Considered
 Figure 17. Perindopril tert-Butylamine Tablets Sales Share by Manufacturers in 2023
 Figure 18. Global Perindopril tert-Butylamine Tablets Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Perindopril tert-Butylamine Tablets Players: Market Share by Revenue in Perindopril tert-Butylamine Tablets in 2023
 Figure 20. Perindopril tert-Butylamine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Perindopril tert-Butylamine Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Perindopril tert-Butylamine Tablets Sales Market Share by Country (2019-2030)
 Figure 23. North America Perindopril tert-Butylamine Tablets Revenue Market Share by Country (2019-2030)
 Figure 24. United States Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Perindopril tert-Butylamine Tablets Sales Market Share by Country (2019-2030)
 Figure 27. Europe Perindopril tert-Butylamine Tablets Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Perindopril tert-Butylamine Tablets Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Perindopril tert-Butylamine Tablets Revenue Market Share by Region (2019-2030)
 Figure 35. China Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Perindopril tert-Butylamine Tablets Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Perindopril tert-Butylamine Tablets Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Perindopril tert-Butylamine Tablets Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Perindopril tert-Butylamine Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Perindopril tert-Butylamine Tablets by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Perindopril tert-Butylamine Tablets by Type (2019-2030)
 Figure 54. Global Perindopril tert-Butylamine Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Perindopril tert-Butylamine Tablets by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Perindopril tert-Butylamine Tablets by Application (2019-2030)
 Figure 57. Global Perindopril tert-Butylamine Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 58. Perindopril tert-Butylamine Tablets Value Chain
 Figure 59. Perindopril tert-Butylamine Tablets Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture